Calliditas Therapeutics AB (CALT)

NASDAQ: CALT · Delayed Price · USD
18.05
0.43 (2.44%)
At close: May 27, 2022 10:08 AM
18.01
-0.04 (-0.22%)
After-hours:May 27, 2022 4:00 PM EDT

Cash Flow Statement (Annual)

Millions SEK. Fiscal year is Jan - Dec.
Year2021202020192018
Net Income
-500.29-433.49-32.58-132.05
Other Operating Activities
38.71124.31-38.433.86
Operating Cash Flow
-461.59-309.18-71.01-128.19
Capital Expenditures
00-0.120
Acquisitions
0-172.600
Change in Investments
0-0.01-1.890
Other Investing Activities
-24.340-16.070
Investing Cash Flow
-24.34-172.61-18.070
Share Issuance / Repurchase
303.09795.45197.65714.22
Debt Issued / Paid
179.09-3.97-1.65-0.47
Other Financing Activities
-47.02-22.922.832.83
Financing Cash Flow
435.16768.56198.84716.57
Net Cash Flow
-50.77286.77109.75588.38
Free Cash Flow
-461.59-309.18-71.13-128.19
Free Cash Flow Margin
-201.26%-35375.40%-38.48%-
Free Cash Flow Per Share
-18.48-13.36-3.07-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).